Table 3.

Demographics of NETs (Sample sets 1–3)

Sample set	Sample no.	Gender	Age range	Site	Metastases	Treatment #
1	T1	M	45-49	Ileum	N	N
1	T2	F	60-64	Ileum	N	N
1	T3	F	45-49	Ileum	N	N
1	T4	M	65-69	Ileum	N	N
1	T5	F	85-89	Ileum	N	N
1	T6	M	40-44	Ileum	N	N
1	T7	F	65-69	Ileum	N	N
1	T8	M	65-69	Ileum	N	N
1	T9	F	55-59	Ileum	N	N
2	T1	M	70-74	Ileum	N	N
2	T2	M	80-84	Ileocecal junction	N	N
2	T3	F	60-64	Ileum	N	N
2	T4	M	50-54	Liver*	Y	Y
2	T5	F	60-64	Liver*	Y	Y
2	T6	F	75-79	Liver*	Y	Y
3	T1	F	65-69	Ileum	N	N
3	T2	F	60-64	Ileum	Y	N
3	T3	M	65-69	Ileum	Y	Y
3	T4	M	65-69	Ileum	Y	Y
3	T5	F	60-64	Ileum	N	N
3	T6	M	75-79	Ileum	N	N
3	T7	F	60-64	Ileum	N	N
3	T8	F	55-59	Ileum	N	N
3	T9	M	40-44	Ileum	Y	N
3	T10	M	45-49	Ileum	N	N
3	T11	M	50-54	Ileum	N	N
3	T12	F	45-49	Ileum	N	N
3	T13	F	50-54	Ileum	Y	N

^#Treatment included somatostatin analogs and/or interferon [21].

*All patients had carcinoid syndrome [21] so presumably the primary tumors were derived from the small intestine.

Female = female, M = Male, N = No, Y = Yes.